97
Participants
Start Date
March 8, 2021
Primary Completion Date
September 27, 2025
Study Completion Date
November 1, 2026
TAK-186
TAK-186 IV infusion.
Scientia Clinical Research Limited, Randwick
Chris O'Brien Lifehouse Hospital, Sydney
Avera Cancer Institute at Sioux Falls, Heidelberg
Paula Fox Melanoma and Cancer Centre, Melbourne
Seoul National University Hospital, Seoul
Monash University - Australian Centre for Blood Diseases (ACBD), Clayton
Severance Hospital Yonsei University Health System, Seoul
Southern Oncology Clinical Research, Bedford Park
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Columbia University Medical Center -161 Fort Washington, New York
Georgetown University Medical Center, Washington D.C.
Moffitt Cancer Center, Tampa
Indiana University, Indianapolis
Mary Crowley Cancer Research Centers Medical City - SCRI - PPDS, Dallas
UC San Diego Moores Cancer Center, San Diego
University of California San Francisco, San Francisco
Fred Hutchinson Cancer Research Center - 1100 Fairview Ave N, Seattle
University of Colorado - Anschutz Medical Campus - PPDS, Aurora
Yale University, New Haven
Northwestern University, Chicago
University of Minnesota Medical Center, Fairview, Minneapolis
Novant Health Cancer Institute - Elizabeth Head and Neck, Charlotte
Sanford Cancer Center, Sioux Falls
MD Anderson Cancer Center, Houston
Sarah Cannon Research Institute UK - SCRI - PPDS, London
The Christie - PPDS, Manchester
Lead Sponsor
Takeda
INDUSTRY